COVID-19 Treatment—Current Status, Advances, and Gap

Chian Ho and Lee, Ping Chin (2022) COVID-19 Treatment—Current Status, Advances, and Gap. Pathogens, 11. pp. 1-15. ISSN 2076-0817

[img] Text
Abstract.pdf

Download (42kB)
[img] Text
Full text.pdf
Restricted to Registered users only

Download (318kB) | Request a copy

Abstract

COVID-19, which emerged in December 2019, was declared a global pandemic by the World Health Organization (WHO) in March 2020. The disease was caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). It has caused millions of deaths worldwide and caused social and economic disruption. While clinical trials on therapeutic drugs are going on in an Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV) public–private partnership collaboration, current therapeutic approaches and options to counter COVID-19 remain few. Therapeutic drugs include the FDA-approved antiviral drugs, Remdesivir, and an immune modulator, Baricitinib. Hence, therapeutic approaches and alternatives for COVID-19 treatment need to be broadened. This paper discusses efforts in approaches to find treatment for COVID-19, such as inhibiting viral entry and disrupting the virus life cycle, and highlights the gap that needs to be filled in these approaches.

Item Type: Article
Keyword: COVID-19 , Peptides , Virus life cycle , FDA-approved drugs , Drug development
Subjects: R Medicine > RA Public aspects of medicine > RA1-1270 Public aspects of medicine > RA421-790.95 Public health. Hygiene. Preventive medicine > RA643-645 Disease (Communicable and noninfectious) and public health
R Medicine > RA Public aspects of medicine > RA1-1270 Public aspects of medicine > RA421-790.95 Public health. Hygiene. Preventive medicine > RA648.5-767 Epidemics. Epidemiology. Quarantine. Disinfection
Department: INSTITUTE > Biotechnology Research Institute (BRI)
Depositing User: SITI AZIZAH BINTI IDRIS -
Date Deposited: 23 Mar 2023 10:12
Last Modified: 23 Mar 2023 10:12
URI: https://eprints.ums.edu.my/id/eprint/35232

Actions (login required)

View Item View Item